CohBar Completes IPO To Develop Mitochondrial-Derived Therapeutics

CohBar, Inc., a biotechnology company focused on discovering mitochondrial-derived peptides and...

Protein Kinase C Enzymes Believed To Promote Cancer Actually Suppress It

Upending decades-old dogma, researchers say enzymes long categorized as promoting cancer are, in...

Reducing Myc Gene Activity Extends Healthy Lifespan In Mice

A team of scientists based at Brown University has found that reducing expression of a fundamentally...

M6P Deficiency Leaves B Cells Out Of Sorts

A group of white blood cells known as B cells play a key role in the human immune response but...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Researchers from McGill University, the California Institute of Technology, the Curie Institute in Paris, Princeton University and other institutions, have unearthed crystalline magnetic fossils of a previously unknown species of microorganism that lived at the boundary of the Paleocene and Eocene epochs, some 55 million years ago. The research might help scientists understand more thoroughly the potential effects of significant changes in the Earth's climate. Though they are only some four microns long, these newly discovered, spear-shaped magnetite crystals (magnetofossils) – unearthed at a dig in New Jersey – are up to eight times larger than previously known magnetofossils.
A drug which was developed in Cambridge and initially designed to treat a form of leukaemia has also proven effective against combating the debilitating neurological disease multiple sclerosis (MS).

The study, led by researchers from the University of Cambridge, has found that alemtuzumab not only stops MS from advancing in patients with early stage active relapsing-remitting multiple sclerosis (RRMS) but may also restore lost function caused by the disease. The findings were published today in the New England Journal of Medicine.
Chandrayaan-1, India’s first mission to the Moon, was successfully launched earlier this morning from the Satish Dhawan Space Centre (SHAR) in Sriharikota, India.

The PSLV-C11 rocket, an upgraded version of the Indian Space Research Organization’s (ISRO’s) Polar Satellite Launch Vehicle, lifted off at 02:52 Central European Summer Time (CEST) and injected the spacecraft into a highly elongated orbit around the Earth. 

Chandrayaan-1 is led by ISRO and the international partners include ESA, Bulgaria and the USA.

The following makes perfect sense - to the government. Let companies that generate no carbon emissions now be treated like they do. Sell those 'emission rights' to companies that are heavier polluters in an auction format, highest bidder wins. Force companies to participate and bid each other up by imposing penalties if they exceed their allowed emissions. Net effect on actual pollution - none. Net effect to the government? Billions. Including a new work force to oversee it all. Then they can use the money in 'awareness' programs to promote energy efficiency. Seriously, are any of you not aware there is pollution by now? Will more television ads help? The only thing more ridiculous would be subsidizing appliances that claim to be lower energy.

Researchers say they have assembled the most complete catalog to date of the genetic changes underlying the most common form of lung cancer. They identified 26 genes that are frequently mutated in a type of cancer called lung adenocarcinoma, a finding that more than doubles the number of genes already known to be linked to the deadly disease.

More than 1 million people worldwide die of lung cancer each year, including more than 160,000 in the United States. About 40 percent of them are adenocarcinoma, a type of non-small cell lung cancer and one that is exceedingly difficult to treat. Only about 15 percent of patients are still alive five years after diagnosis.

Cortisol helps our bodies cope with stress, but what about its effects on the brain? A new study appearing in the October 15th issue of Biological Psychiatry, says that in an animal model of posttraumatic stress disorder (PTSD), high doses of a cortisol-related substance, corticosterone, prevented negative consequences of stress exposure, including increased startle response and behavioral freezing when exposed to reminders of the stress.

However, low-dose corticosterone potentiated these responses. This finding suggests that corticosterone levels may influence both vulnerability and resilience in a dose-dependent manner through its involvement in memory processes.